The Total number of records shown on this page is 100. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
OV_2878	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	Laboratory grown own culture	Osteosarcoma cell line	HOS	5.0E+3 cells per well	NA	MTT assay	10 MOI	5% cell survival	No	No	NA	No response	NA	NA	NA	NA	23816608
OV_2879	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	Laboratory grown own culture	Neuroblastoma cell line	IMR-5	5.0E+3 cells per well	NA	MTT assay	0.01 MOI	78% cell survival	No	No	NA	No response	NA	NA	NA	NA	23816608
OV_2880	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	Laboratory grown own culture	Neuroblastoma cell line	IMR-5	5.0E+3 cells per well	NA	MTT assay	0.1 MOI	70% cell survival	No	No	NA	No response	NA	NA	NA	NA	23816608
OV_2881	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	Laboratory grown own culture	Neuroblastoma cell line	IMR-5	5.0E+3 cells per well	NA	MTT assay	1 MOI	60% cell survival	No	No	NA	No response	NA	NA	NA	NA	23816608
OV_2882	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	Laboratory grown own culture	Neuroblastoma cell line	IMR-5	5.0E+3 cells per well	NA	MTT assay	10 MOI	50% cell survival	No	No	NA	No response	NA	NA	NA	NA	23816608
OV_2883	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	Laboratory grown own culture	Neuroblastoma cell line	IMR-32	5.0E+3 cells per well	NA	MTT assay	0.01 MOI	50% cell survival	No	No	NA	No response	NA	NA	NA	NA	23816608
OV_2884	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	Laboratory grown own culture	Neuroblastoma cell line	IMR-32	5.0E+3 cells per well	NA	MTT assay	0.1 MOI	42% cell survival	No	No	NA	No response	NA	NA	NA	NA	23816608
OV_2885	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	Laboratory grown own culture	Neuroblastoma cell line	IMR-32	5.0E+3 cells per well	NA	MTT assay	1 MOI	38% cell survival	No	No	NA	No response	NA	NA	NA	NA	23816608
OV_2886	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	Laboratory grown own culture	Neuroblastoma cell line	IMR-32	5.0E+3 cells per well	NA	MTT assay	10 MOI	20% cell survival	No	No	NA	No response	NA	NA	NA	NA	23816608
OV_2887	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	Laboratory grown own culture	Neuroblastoma cell line	SK-N-AS	5.0E+3 cells per well	NA	MTT assay	0.01 MOI	70% cell survival	No	No	NA	No response	NA	NA	NA	NA	23816608
OV_2888	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	Laboratory grown own culture	Neuroblastoma cell line	SK-N-AS	5.0E+3 cells per well	NA	MTT assay	0.1 MOI	40% cell survival	No	No	NA	No response	NA	NA	NA	NA	23816608
OV_2889	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	Laboratory grown own culture	Neuroblastoma cell line	SK-N-AS	5.0E+3 cells per well	NA	MTT assay	1 MOI	30% cell survival	No	No	NA	No response	NA	NA	NA	NA	23816608
OV_2890	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	Laboratory grown own culture	Neuroblastoma cell line	SK-N-AS	5.0E+3 cells per well	NA	MTT assay	10 MOI	20% cell survival	No	No	NA	No response	NA	NA	NA	NA	23816608
OV_2891	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	Laboratory grown own culture	Neuroblastoma cell line	SKNBE2	5.0E+3 cells per well	NA	MTT assay	0.01 MOI	50% cell survival	No	No	NA	No response	NA	NA	NA	NA	23816608
OV_2892	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	Laboratory grown own culture	Neuroblastoma cell line	SKNBE2	5.0E+3 cells per well	NA	MTT assay	0.1 MOI	40% cell survival	No	No	NA	No response	NA	NA	NA	NA	23816608
OV_2893	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	Laboratory grown own culture	Neuroblastoma cell line	SKNBE2	5.0E+3 cells per well	NA	MTT assay	1 MOI	38% cell survival	No	No	NA	No response	NA	NA	NA	NA	23816608
OV_2894	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	Laboratory grown own culture	Neuroblastoma cell line	SKNBE2	5.0E+3 cells per well	NA	MTT assay	10 MOI	20% cell survival	No	No	NA	No response	NA	NA	NA	NA	23816608
OV_2895	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	Laboratory grown own culture	Neuroblastoma cell line	BT16GFPFluc	NA	NA	NA	NA	NA	CD-1 mice xenograft for cell line (1.0E+5)	5.0E+7 pfu	NA	Significant reduction in tumor volume	NA	NA	NA	NA	23816608
OV_2896	Vaccinia virus	vvDD	DNA	Poxviridae	Deletion of TK gene and vaccinia growth factor	Yes	No	No	Laboratory grown own culture	Neuroblastoma cell line SKNASmCherryFluc	SK-N-ASmCherryFluc	NA	NA	NA	NA	NA	CB17 SCID mice xenograft for cell line (5.0E+6)	5.0E+7 pfu	NA	Significant reduction in tumor volume	NA	NA	NA	NA	23816608
OV_3045	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	ATCC	Human cervical cancer cell line	HeLa	3.0E+5 cells per well	NA	Trypan blue assay	10⁻⁴ MOI	30% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3046	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	ATCC	Human cervical cancer cell line	HeLa	3.0E+5 cells per well	NA	Trypan blue assay	10⁻³ MOI	100% cell death	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3047	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	ATCC	Human cervical cancer cell line	HeLa	3.0E+5 cells per well	NA	Trypan blue assay	10⁻² MOI	100% cell death	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3048	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	ATCC	Human colon cancer cell line	LoVo	3.0E+5 cells per well	NA	Trypan blue assay	10⁻⁴ MOI	100% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3049	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	ATCC	Human colon cancer cell line	LoVo	3.0E+5 cells per well	NA	Trypan blue assay	10⁻³ MOI	70% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3050	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	ATCC	Human colon cancer cell line	LoVo	3.0E+5 cells per well	NA	Trypan blue assay	10⁻² MOI	15% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3051	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	ATCC	Human lung cancer cell line	A549	3.0E+5 cells per well	NA	Trypan blue assay	10⁻⁴ MOI	18% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3052	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	ATCC	Human lung cancer cell line	A549	3.0E+5 cells per well	NA	Trypan blue assay	10⁻³ MOI	10% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3053	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	ATCC	Human lung cancer cell line	A549	3.0E+5 cells per well	NA	Trypan blue assay	10⁻² MOI	1% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3054	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	ATCC	Human glioblastoma cell line	U-87 MG	3.0E+5 cells per well	NA	Trypan blue assay	10⁻⁴ MOI	30% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3055	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	ATCC	Human glioblastoma cell line	U-87 MG	3.0E+5 cells per well	NA	Trypan blue assay	10⁻³ MOI	10% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3056	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	ATCC	Human glioblastoma cell line	U-87 MG	3.0E+5 cells per well	NA	Trypan blue assay	10⁻² MOI	1% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3057	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	ATCC	Human hepatocellular carcinoma cell line	HepG2	3.0E+5 cells per well	NA	Trypan blue assay	10⁻⁴ MOI	18% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3058	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	ATCC	Human hepatocellular carcinoma cell line	HepG2	3.0E+5 cells per well	NA	Trypan blue assay	10⁻³ MOI	1% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3059	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	ATCC	Human hepatocellular carcinoma cell line	HepG2	3.0E+5 cells per well	NA	Trypan blue assay	10⁻² MOI	100% cell death	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3060	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	ATCC	Human bladder cancer cell line	SW780	3.0E+5 cells per well	NA	Trypan blue assay	10⁻⁴ MOI	50% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3061	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	ATCC	Human bladder cancer cell line	SW780	3.0E+5 cells per well	NA	Trypan blue assay	10⁻³ MOI	10% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3062	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	ATCC	Human bladder cancer cell line	SW780	3.0E+5 cells per well	NA	Trypan blue assay	10⁻² MOI	100% cell death	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3063	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	ECACC	Human eosophageal cancer cell line	OE19	3.0E+5 cells per well	NA	Trypan blue assay	10⁻⁴ MOI	80% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3064	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	ECACC	Human eosophageal cancer cell line	OE19	3.0E+5 cells per well	NA	Trypan blue assay	10⁻³ MOI	50% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3065	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	ECACC	Human eosophageal cancer cell line	OE19	3.0E+5 cells per well	NA	Trypan blue assay	10⁻² MOI	10% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3066	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	Cantren Antoine- lacassagne, France	Human head and neck squamous cell carcinoma cell line	CAL33	3.0E+5 cells per well	NA	Trypan blue assay	10⁻⁴ MOI	18% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3067	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	Cantren Antoine- lacassagne, France	Human head and neck squamous cell carcinoma cell line	CAL33	3.0E+5 cells per well	NA	Trypan blue assay	10⁻³ MOI	1% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3068	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	Cantren Antoine- lacassagne, France	Human head and neck squamous cell carcinoma cell line	CAL33	3.0E+5 cells per well	NA	Trypan blue assay	10⁻² MOI	100% cell death	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3069	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	ATCC	Human stomach cancer cell line	Hs746T	3.0E+5 cells per well	NA	Trypan blue assay	10⁻⁴ MOI	18% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3070	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	ATCC	Human stomach cancer cell line	Hs746T	3.0E+5 cells per well	NA	Trypan blue assay	10⁻³ MOI	1% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3071	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	ATCC	Human stomach cancer cell line	Hs746T	3.0E+5 cells per well	NA	Trypan blue assay	10⁻² MOI	100% cell death	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3072	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	ATCC	Human colon cancer cell line	HCT-116	3.0E+5 cells per well	NA	Trypan blue assay	10⁻⁴ MOI	30% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3073	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	ATCC	Human colon cancer cell line	HCT-116	3.0E+5 cells per well	NA	Trypan blue assay	10⁻³ MOI	5% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3074	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	ATCC	Human colon cancer cell line	HCT-116	3.0E+5 cells per well	NA	Trypan blue assay	10⁻² MOI	1% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3075	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	ATCC	Human cervical cancer cell line	HeLa	3.0E+5 cells per well	NA	Trypan blue assay	10⁻⁴ MOI	18% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3076	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	ATCC	Human cervical cancer cell line	HeLa	3.0E+5 cells per well	NA	Trypan blue assay	10⁻³ MOI	1% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3077	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	ATCC	Human cervical cancer cell line	HeLa	3.0E+5 cells per well	NA	Trypan blue assay	10⁻² MOI	1% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3078	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	ATCC	Human colon cancer cell line	LoVo	3.0E+5 cells per well	NA	Trypan blue assay	10⁻⁴ MOI	100% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3079	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	ATCC	Human colon cancer cell line	LoVo	3.0E+5 cells per well	NA	Trypan blue assay	10⁻³ MOI	70% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3080	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	ATCC	Human colon cancer cell line	LoVo	3.0E+5 cells per well	NA	Trypan blue assay	10⁻² MOI	15% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3081	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	ATCC	Human lung cancer cell line	A549	3.0E+5 cells per well	NA	Trypan blue assay	10⁻⁴ MOI	30% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3082	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	ATCC	Human lung cancer cell line	A549	3.0E+5 cells per well	NA	Trypan blue assay	10⁻³ MOI	15% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3083	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	ATCC	Human lung cancer cell line	A549	3.0E+5 cells per well	NA	Trypan blue assay	10⁻² MOI	5% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3084	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	ATCC	Human glioblastoma cell line	U-87 MG	3.0E+5 cells per well	NA	Trypan blue assay	10⁻⁴ MOI	30% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3085	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	ATCC	Human glioblastoma cell line	U-87 MG	3.0E+5 cells per well	NA	Trypan blue assay	10⁻³ MOI	15% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3086	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	ATCC	Human glioblastoma cell line	U-87 MG	3.0E+5 cells per well	NA	Trypan blue assay	10⁻² MOI	5% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3087	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	ATCC	Human hepatocellular carcinoma cell line	HepG2	3.0E+5 cells per well	NA	Trypan blue assay	10⁻⁴ MOI	15% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3088	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	ATCC	Human hepatocellular carcinoma cell line	HepG2	3.0E+5 cells per well	NA	Trypan blue assay	10⁻³ MOI	1% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3089	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	ATCC	Human hepatocellular carcinoma cell line	HepG2	3.0E+5 cells per well	NA	Trypan blue assay	10⁻² MOI	100% cell death	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3090	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	ATCC	Human bladder cancer cell line	SW780	3.0E+5 cells per well	NA	Trypan blue assay	10⁻⁴ MOI	45% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3091	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	ATCC	Human bladder cancer cell line	SW780	3.0E+5 cells per well	NA	Trypan blue assay	10⁻³ MOI	15% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3092	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	ATCC	Human bladder cancer cell line	SW780	3.0E+5 cells per well	NA	Trypan blue assay	10⁻² MOI	100% cell death	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3093	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	ECACC	Human eosophageal cancer cell line	OE19	3.0E+5 cells per well	NA	Trypan blue assay	10⁻⁴ MOI	85% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3094	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	ECACC	Human eosophageal cancer cell line	OE19	3.0E+5 cells per well	NA	Trypan blue assay	10⁻³ MOI	45% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3095	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	ECACC	Human eosophageal cancer cell line	OE19	3.0E+5 cells per well	NA	Trypan blue assay	10⁻² MOI	5% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3096	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	Cantren Antoine- lacassagne, France	Human head and neck squamous cell carcinoma cell line	CAL33	3.0E+5 cells per well	NA	Trypan blue assay	10⁻⁴ MOI	18% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3097	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	Cantren Antoine- lacassagne, France	Human head and neck squamous cell carcinoma cell line	CAL33	3.0E+5 cells per well	NA	Trypan blue assay	10⁻³ MOI	2% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3098	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	Cantren Antoine- lacassagne, France	Human head and neck squamous cell carcinoma cell line	CAL33	3.0E+5 cells per well	NA	Trypan blue assay	10⁻² MOI	100% cell death	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3099	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	ATCC	Human stomach cancer cell line	Hs746T	3.0E+5 cells per well	NA	Trypan blue assay	10⁻⁴ MOI	18% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3100	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	ATCC	Human stomach cancer cell line	Hs746T	3.0E+5 cells per well	NA	Trypan blue assay	10⁻³ MOI	2% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3101	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	ATCC	Human stomach cancer cell line	Hs746T	3.0E+5 cells per well	NA	Trypan blue assay	10⁻² MOI	100% cell death	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3102	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	ATCC	Human colon cancer cell line	HCT-116	3.0E+5 cells per well	NA	Trypan blue assay	10⁻⁴ MOI	30% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3103	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	ATCC	Human colon cancer cell line	HCT-116	3.0E+5 cells per well	NA	Trypan blue assay	10⁻³ MOI	10% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3104	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	ATCC	Human colon cancer cell line	HCT-116	3.0E+5 cells per well	NA	Trypan blue assay	10⁻² MOI	1% cell death	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3105	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	No	Virus strain in combination with 5-FC (200mg/kg)	No	ATCC	Human colon cancer cell line	LoVo	NA	NA	NA	NA	NA	BD62 mice xenograft for Lovo cell line	1.0E+7 pfu	NA	Tumor volume decreases to below 500mm after 50 days	Intravenous	NA	NA	NA	31011628
OV_3106	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	No	Virus strain in combination with 5-FC (200mg/kg)	No	ATCC	Human colon cancer cell line	LoVo	NA	NA	NA	NA	NA	BD62 mice xenograft for Lovo cell line	1.0E+7 pfu	NA	Tumor volume decreases to 500mm after 50 days	Intravenous	NA	NA	NA	31011628
OV_3107	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	No	Virus strain in combination with 5-FC (200mg/kg)	No	ECACC	Human colon cancer cell line	OE19	NA	NA	NA	NA	NA	BD62 mice xenograft for Lovo cell line	1.0E+7 pfu	NA	Tumor volume decreases to below 1000 mm after 50 days	Intravenous	NA	NA	NA	31011628
OV_3108	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	No	Virus strain in combination with 5-FC (200mg/kg)	No	ECACC	Human colon cancer cell line	OE19	NA	NA	NA	NA	NA	BD62 mice xenograft for Lovo cell line	1.0E+7 pfu	NA	Tumor volume decreases to 250 mm after 50 days	Intravenous	NA	NA	NA	31011628
OV_3109	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	No	Virus strain in combination with 5-FC (200mg/kg)	No	ATCC	Human bladder cancer cell line	SW780	NA	NA	NA	NA	NA	BD62 mice xenograft for Lovo cell line	1.0E+7 pfu	NA	Tumor volume decreases to below 100 mm after 50 days	Intravenous	NA	NA	NA	31011628
OV_3110	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	No	Virus strain in combination with 5-FC (200mg/kg)	No	ATCC	Human bladder cancer cell line	SW780	NA	NA	NA	NA	NA	BD62 mice xenograft for Lovo cell line	1.0E+7 pfu	NA	Tumor volume decreases to below 100 mm after 50 days	Intravenous	NA	NA	NA	31011628
OV_3111	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	No	Virus strain in combination with 5-FC (200mg/kg)	No	ATCC	Human hepatocellular carcinoma cell line	HepG2	NA	NA	NA	NA	NA	BD62 mice xenograft for Lovo cell line	1.0E+7 pfu	NA	Tumor volume decreases to below 1500 mm after 50 days	Intravenous	NA	NA	NA	31011628
OV_3112	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	No	Virus strain in combination with 5-FC (200mg/kg)	No	ATCC	Human hepatocellular carcinoma cell line	HepG2	NA	NA	NA	NA	NA	BD62 mice xenograft for Lovo cell line	1.0E+7 pfu	NA	Tumor volume decreases to below 1000 mm after 50 days	Intravenous	NA	NA	NA	31011628
OV_3113	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	No	Virus strain in combination with 5-FC (200mg/kg)	No	ATCC	Human stomach cancer cell line	Hs746T	NA	NA	NA	NA	NA	BD62 mice xenograft for Lovo cell line	1.0E+7 pfu	NA	Tumor volume decreases to below 3500 mm after 50 days	Intravenous	NA	NA	NA	31011628
OV_3114	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	No	Virus strain in combination with 5-FC (200mg/kg)	No	ATCC	Human stomach cancer cell line	Hs746T	NA	NA	NA	NA	NA	BD62 mice xenograft for Lovo cell line	1.0E+7 pfu	NA	Tumor volume decreases to below 1000 mm after 50 days	Intravenous	NA	NA	NA	31011628
OV_3115	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	No	Virus strain in combination with 5-FC (200mg/kg)	No	Cantren Antoine- lacassagne, France	Human head and neck squamous cell carcinoma cell line	CAL33	NA	NA	NA	NA	NA	BD62 mice xenograft for Lovo cell line	1.0E+7 pfu	NA	Tumor volume decreases to below 100 mm after 50 days	Intravenous	NA	NA	NA	31011628
OV_3116	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	No	Virus strain in combination with 5-FC (200mg/kg)	No	Cantren Antoine- lacassagne, France	Human head and neck squamous cell carcinoma cell line	CAL33	NA	NA	NA	NA	NA	BD62 mice xenograft for Lovo cell line	1.0E+7 pfu	NA	Tumor volume decreases to below 100 mm after 50 days	Intravenous	NA	NA	NA	31011628
OV_3117	Vaccinia virus	Vaccinia virus deltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	No	Virus strain in combination with 5-FC (200mg/kg)	No	ATCC	Human colon cancer cell line	HCT-116	NA	NA	NA	NA	NA	BD62 mice xenograft for Lovo cell line	1.0E+7 pfu	NA	Tumor volume decreases to below 500 mm after 50 days	Intravenous	NA	NA	NA	31011628
OV_3118	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	No	Virus strain in combination with 5-FC (200mg/kg)	No	ATCC	Human colon cancer cell line	HCT-116	NA	NA	NA	NA	NA	BD62 mice xenograft for Lovo cell line	1.0E+7 pfu	NA	Tumor volume decreases to below 100 mm after 50 days	Intravenous	NA	NA	NA	31011628
OV_3189	Vaccinia virus	wild type	DNA	Poxviridae	None	Yes	No	No	ATCC	Human edwig sarcoma cell line	RD-ES	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.0001 MOI	75% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3190	Vaccinia virus	wild type	DNA	Poxviridae	None	Yes	No	No	ATCC	Human edwig sarcoma cell line	RD-ES	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.001 MOI	50% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3191	Vaccinia virus	wild type	DNA	Poxviridae	None	Yes	No	No	ATCC	Human edwig sarcoma cell line	RD-ES	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.01 MOI	45% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3192	Vaccinia virus	wild type	DNA	Poxviridae	None	Yes	No	No	ATCC	Human edwig sarcoma cell line	RD-ES	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.1 MOI	45% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3193	Vaccinia virus	wild type	DNA	Poxviridae	None	Yes	No	No	ATCC	Human edwig sarcoma cell line	RD-ES	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	1 MOI	40% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3194	Vaccinia virus	wild type	DNA	Poxviridae	None	Yes	No	No	ATCC	Human edwig sarcoma cell line	RD-ES	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	10 MOI	45% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3219	Vaccinia virus	wild type	DNA	Poxviridae	None	Yes	No	No	ATCC	Human bone osteosarcoma cell line	143-B	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.0001 MOI	75% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891